Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | GAA | P10253 | 1/20 | 0.64 |
| ▸ | MAOB | P27338 | 2/20 | 0.49 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | KCNA2 | P16389 | 1/20 | 0.46 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.46 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.45 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.44 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.44 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | EDNRA | P25101 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14129739 | 0.88 | LMNA (0.61) | LMNAGAAMAOBMAOAKCNA2 | |
| SCHEMBL4545464 | 0.86 | LMNA (0.62) | LMNAGAAMAOBMAOAKCNA2 | |
| SCHEMBL13226830 | 0.85 | LMNA (0.60) | LMNAGAAMAOBMAOAKCNA2 | |
| SCHEMBL19329825 | 0.84 | LMNA (0.56) | LMNAGAAMAOBMAOAKCNA2 | |
| SCHEMBL4545472 | 0.84 | LMNA (0.63) | LMNAGAAMAOBMAOAKCNA2 | |
| SCHEMBL10635640 | 0.83 | MRGPRX4 (0.52) | LMNAGAAMAOBSMN1; SMN2 | |
| SCHEMBL23223241 | 0.83 | LMNA (0.58) | LMNAGAAMAOBMAOAKCNA2 | |
| SCHEMBL19329810 | 0.83 | LMNA (0.58) | LMNAGAAMAOBMAOAKCNA2 | |
| SCHEMBL21975951 | 0.82 | LMNA (0.56) | LMNAGAAMAOBMAOAKCNA2 | |
| SCHEMBL13395926 | 0.81 | GAA (0.52) | LMNAGAAMAOBMAOAKCNA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 779 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4735055-A1 | UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR)-PET/CT IN BRAIN TUMOURS | Curasight A/S (DK) | 2026-05-06 | — | — | EP | claimed |
| US-20260077071-A1 | Targeted Delivery of Theranostic Agents | PETER MACCALLUM CANCER INST (AU) | 2026-03-19 | — | — | US | claimed |
| EP-4448020-B1 | UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR)-PET/CT IN NEUROENDOCRINE NEOPLAMS | CURASIGHT AS (DK) | 2026-02-04 | — | — | EP | claimed |
| US-20250360218-A1 | MITOCHONDRIA-TARGETING CANCER THERAPEUTIC COMPOSITION | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2025-11-27 | — | — | US | claimed |
| US-20250049971-A1 | UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR)-PET/CT IN NEUROENDOCRINE NEOPLAMS | CURASIGHT A/S (DK) | 2025-02-13 | — | — | US | claimed |
| EP-4493578-A1 | TARGETED DELIVERY OF THERANOSTIC AGENTS | Peter MacCallum Cancer Institute (AU) | 2025-01-22 | — | — | EP | claimed |
| CN-119272149-A | Atmospheric environment monitoring fixed site pollutant monitoring data backtracking method | 同济大学 | 2025-01-07 | — | — | CN | claimed |
| WO-2025003190-A1 | UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR)-PET/CT IN BRAIN TUMOURS | CURASIGHT A/S (DK) | 2025-01-02 | — | — | WO | claimed |
| EP-4448020-A1 | UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR)-PET/CT IN NEUROENDOCRINE NEOPLAMS | Curasight A/S (DK) | 2024-10-23 | — | — | EP | claimed |
| CN-118695877-A | Urokinase-type plasminogen activator receptor (UPAR) -PET/CT in neuroendocrine tumors | 库拉赛特股份公司 | 2024-09-24 | — | — | CN | claimed |
| CN-110128383-B | Preparation method of 3- (benzyloxy) -4-oxo-4H-pyran-2-carboxylic acid | 南京焕然生物科技有限公司 | 2022-03-11 | — | — | CN | claimed |
| CN-112266390-B | Preparation method of Barosavir intermediate | 南京法恩化学有限公司 | 2022-03-08 | — | — | CN | claimed |
| CN-113845502-A | Preparation method of 3- (benzyloxy) -4-oxo-4H-pyran-2-carboxylic acid | 山东诚创蓝海医药科技有限公司 | 2021-12-28 | — | — | CN | claimed |
| CN-112574155-A | Synthetic method of 3- (benzyloxy) -4-oxo-4H-pyran-2-carboxylic acid | 南京杰运医药科技有限公司 | 2021-03-30 | — | — | CN | claimed |
| CN-112266390-A | Preparation method of Barosavir intermediate | 南京法恩化学有限公司 | 2021-01-26 | — | — | CN | claimed |
| WO-2020132820-A1 | SYNTHESIS METHOD FOR 3-(BENZYLOXY)-4-OXO-4H-PYRAN-2-CARBOXYLIC ACID | 广东莱佛士制药技术有限公司 | 2020-07-02 | — | — | WO | claimed |
| CN-210612935-U | 3- (benzyloxy) -4-oxo-4H-pyran-2-carboxylic acid apparatus for producing | 宁波人健化学制药有限公司 | 2020-05-26 | — | — | CN | claimed |
| CN-111018803-A | Preparation method of Barosavir intermediate | 苏州楚凯药业有限公司 | 2020-04-17 | — | — | CN | claimed |
| CN-110128383-A | A kind of preparation method of 3- (benzyloxy) -4- oxo -4H- pyrans -2- carboxylic acid | 南京焕然生物科技有限公司 | 2019-08-16 | — | — | CN | claimed |
| CN-109438405-A | A kind of synthetic method of 3- (benzyloxy) -4- oxo -4H- pyrans -2- carboxylic acid | 广东莱佛士制药技术有限公司 | 2019-03-08 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250360218-A1 | MITOCHONDRIA-TARGETING CANCER THERAPEUTIC COMPOSITION | TSPO, TFAM, MCU | LMNA 1398/4885GAA 1887/4885MAOB 2896/4885 |
| US-20260077071-A1 | Targeted Delivery of Theranostic Agents | CCKAR, NPY1R, NPY2R | LMNA 1248/4885GAA 1074/4885MAOB 4031/4885 |
| US-20250049971-A1 | UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR)-PET/CT IN NEUROENDOCRINE NEOPLAMS | PLAUR, PLAU, PROKR1 | LMNA 1395/4885GAA 1322/4885MAOB 2479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.